In this case, direct thrombin replacement for her hypoprothrombinemia was primarily achieved through prothrombin complex concentrate, and fresh plasma and cryoprecipitate were used specifically to address the anticipated hypofibrinogenemia following cardiopulmonary bypass. The gene discussed is F2; the disease is Congenital factor II deficiency.